Citigroup Issues Pessimistic Forecast for Sherwin-Williams (NYSE:SHW) Stock Price

Sherwin-Williams (NYSE:SHW) had its price objective reduced by equities researchers at Citigroup from $410.00 to $385.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the specialty chemicals company’s stock. Citigroup’s price target points to a potential upside of 21.19% from the stock’s current price.

Several other analysts have also recently commented on the company. Weiss Ratings restated a “hold (c+)” rating on shares of Sherwin-Williams in a report on Friday, March 27th. Royal Bank Of Canada cut their price objective on shares of Sherwin-Williams from $390.00 to $376.00 and set an “outperform” rating on the stock in a report on Thursday, March 19th. Zacks Research cut shares of Sherwin-Williams from a “hold” rating to a “strong sell” rating in a research report on Friday, January 30th. UBS Group set a $420.00 price target on shares of Sherwin-Williams in a research report on Friday, January 30th. Finally, Mizuho cut their price target on shares of Sherwin-Williams from $410.00 to $371.00 and set an “outperform” rating on the stock in a research note on Monday, March 23rd. Eleven research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $383.23.

Sherwin-Williams Stock Performance

Sherwin-Williams stock opened at $317.69 on Wednesday. Sherwin-Williams has a fifty-two week low of $301.58 and a fifty-two week high of $379.65. The company has a market capitalization of $78.58 billion, a price-to-earnings ratio of 30.93, a PEG ratio of 2.82 and a beta of 1.27. The stock has a fifty day moving average of $342.95 and a two-hundred day moving average of $339.79. The company has a debt-to-equity ratio of 2.03, a quick ratio of 0.53 and a current ratio of 0.87.

Sherwin-Williams (NYSE:SHW) last announced its earnings results on Thursday, January 29th. The specialty chemicals company reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.16 by $0.07. Sherwin-Williams had a net margin of 10.90% and a return on equity of 65.26%. The firm had revenue of $5.60 billion during the quarter, compared to the consensus estimate of $5.57 billion. During the same quarter in the previous year, the company posted $2.09 EPS. The firm’s revenue for the quarter was up 5.6% on a year-over-year basis. On average, analysts anticipate that Sherwin-Williams will post 12 EPS for the current fiscal year.

Insider Buying and Selling at Sherwin-Williams

In related news, insider Colin M. Davie sold 2,976 shares of the stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $359.50, for a total value of $1,069,872.00. Following the completion of the sale, the insider directly owned 5,365 shares in the company, valued at approximately $1,928,717.50. This represents a 35.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Bryan J. Young sold 2,513 shares of the firm’s stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $364.47, for a total value of $915,913.11. Following the completion of the transaction, the senior vice president directly owned 10,045 shares in the company, valued at $3,661,101.15. This trade represents a 20.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Sherwin-Williams

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Sherwin-Williams by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 23,237,824 shares of the specialty chemicals company’s stock worth $7,529,752,000 after acquiring an additional 600,119 shares during the period. State Street Corp lifted its position in shares of Sherwin-Williams by 2.4% during the fourth quarter. State Street Corp now owns 15,638,974 shares of the specialty chemicals company’s stock worth $5,067,497,000 after purchasing an additional 364,832 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Sherwin-Williams by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 5,231,615 shares of the specialty chemicals company’s stock valued at $1,687,498,000 after purchasing an additional 37,145 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its stake in shares of Sherwin-Williams by 9.9% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 3,887,808 shares of the specialty chemicals company’s stock valued at $1,334,918,000 after purchasing an additional 351,453 shares during the period. Finally, Capital Research Global Investors grew its holdings in Sherwin-Williams by 0.3% during the 3rd quarter. Capital Research Global Investors now owns 3,432,977 shares of the specialty chemicals company’s stock valued at $1,188,698,000 after purchasing an additional 11,560 shares in the last quarter. Institutional investors and hedge funds own 77.67% of the company’s stock.

Key Sherwin-Williams News

Here are the key news stories impacting Sherwin-Williams this week:

• Positive Sentiment: Zacks upgraded Sherwin-Williams from “strong sell” to “hold,” which reduces downside analyst pressure and is a modest supportive catalyst for the shares. Zacks Upgrade
• Neutral Sentiment: Sherwin-Williams confirmed its Q1 2026 results release date for April 28; ahead of results the stock may see increased volatility as investors re-price expectations. Q1 2026 Results Announcement
• Neutral Sentiment: General market coverage highlighting “out-of-favor” names could keep sentiment cautious for cyclical/industrial names; it’s unclear how prominently Sherwin-Williams features in that piece but the tone can weigh on sentiment. 3 Out-of-Favor Stocks We Find Risky
• Negative Sentiment: UBS lowered its price target on SHW from $420 to $380 while keeping a “buy” rating; a trimmed target from a major shop can pressure the stock despite the maintained buy call. UBS Lowers PT
• Negative Sentiment: Citigroup cut its target from $410 to $385 but also left a “buy” rating in place; another analyst trim likely contributed to intraday selling. Citigroup Lowers PT
• Negative Sentiment: Competitor RPM expanded its building-envelope portfolio with the Kalzip acquisition, which could intensify competition in engineered systems and higher-margin segments — a potential headwind for Sherwin-Williams’ growth/margin outlook. RPM Kalzip Acquisition

About Sherwin-Williams

Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.

The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.